Financial Performance - Group net fees decreased by 11% to £972.4 million[10], while operating profit decreased by 56% to £45.6 million[10] - Basic Earnings Per Share (EPS) decreased by 67%[49] - The company delivered approximately £35 million per annum of structural cost savings in FY25[10, 66, 69, 113] Regional Performance - Germany's net fees decreased by 10% to £308.9 million[12], representing 32% of the Group's net fees[12] - UK & Ireland's net fees decreased by 15% to £192.2 million[21], accounting for 20% of the Group's net fees[21], with an operating loss of £(5.8) million[21] - Australia & New Zealand's net fees decreased by 13% to £116.2 million[29], contributing 12% to the Group's net fees[29] - Rest of World's net fees decreased by 8% to £355.1 million[35], making up 36% of the Group's net fees[35] Segment Performance - Temp & Contracting net fees decreased by 7%[10], while Perm net fees decreased by 17%[10] - Temp & Contracting accounted for 62% of Group net fees in FY25[111] Operational Efficiency - Consultant headcount was reduced by 14% year-over-year[10, 65], leading to a 5% increase in consultant net fee productivity[10, 67] - The company closed 29 offices as part of operational restructurings[65]

Financial Data and Key Metrics Changes - Net sales from continuing operations totaled $24.7 million, down from $28 million in Q1 2024, reflecting broader market softness [4] - Adjusted EBITDA from continuing operations improved significantly, swinging from a loss of $2.7 million in the prior year to a positive $843,000 this quarter, marking a $3.5 million turnaround [5][20] - Gross profit nearly doubled to $4.8 million, or 19.3% of sales, compared to $2.3 million, or 8.3% last year, an expansion of over 1,100 basis points [17] Business Line Data and Key Metrics Changes - Tubular Segments generated $6.9 million in revenue, down slightly year over year, but gross margin increased from 12.3% to 24.8%, with adjusted EBITDA rising nearly five times to $1.3 million [6] - Specialty Chemicals segment revenue declined year over year to $17.8 million, but gross profit increased by $2.1 million, rising from $1.6 million to $3.7 million, a 131% improvement, with gross margin expanding from 7.6% to 21% [9] Market Data and Key Metrics Changes - Average daily trading volume increased to approximately 63,000 shares in Q1 2025, a 60% lift compared to Q1 2024, indicating growing market interest [13] Company Strategy and Development Direction - The company is focused on strategic repositioning, actively choosing to exit low-margin business in favor of higher value, more technically demanding opportunities [15][16] - The goal for the Specialty Chemicals segment is to shift from a 75% commodity and 25% blended mix to a 60% and 40% mix by the end of 2025, aiming for a more balanced portfolio [35] Management's Comments on Operating Environment and Future Outlook - Management noted that while there are signs of improvement, demand remains soft, and they are still evaluating options to monetize the value of their assets [28][29] - The company is not ready to provide forward-looking guidance for 2025, as they are still stabilizing their operations [30][31] Other Important Information - The company ended the quarter with $14.3 million in cash and no debt before the divestiture of Bristol assets for $45 million, providing significant flexibility for capital deployment [21][22] - The company repurchased approximately 17,000 shares at an average price of $12.73, reinforcing confidence in intrinsic value and long-term fundamentals [21] Q&A Session Summary Question: Comments on the ASTI business and its attractiveness as a target - Management indicated that while there are additional looks due to tariffs, demand remains incredibly soft, and the market conditions have not materially changed [28] Question: Possibility of selling ASTI in 2025 - Management confirmed they are always evaluating options to monetize the value of all assets [29] Question: Guidance for profitability in chemicals - Management stated it is premature to provide guidance as they are still stabilizing operations [30][31] Question: Growth plans for chemicals by 2026 - Management expects to see some growth in the second half of the year, with a more compelling top line anticipated in 2026 [33] Question: Capacity and CapEx for growth - Management confirmed that growth can be achieved with existing capacity and minimal CapEx, with a run rate of $1 to $3 million per year [36] Question: Stock buyback limitations - Management explained that the buyback was executed within the confines of the existing program, and optionality has increased post-Bristol sale [37] Question: Perception of stock valuation - Management expressed the opinion that the stock remains undervalued at current levels [38]

Financial Data and Key Metrics Changes - Net sales from continuing operations totaled $24.7 million, down from $28 million in Q1 2024, reflecting broader market softness [4] - Adjusted EBITDA from continuing operations improved significantly, swinging from a loss of $2.7 million in the prior year to a positive $843,000 this quarter, a $3.5 million turnaround [5][21] - Gross profit nearly doubled to $4.8 million, or 19.3% of sales, compared to $2.3 million, or 8.3% last year, an expansion of over 1,100 basis points [17] Business Line Data and Key Metrics Changes - Tubular Segments generated $6.9 million in revenue, down slightly year over year, but gross margin increased from 12.3% to 24.8%, with adjusted EBITDA rising nearly five times to $1.3 million [6] - Specialty Chemicals segment revenue declined year over year to $17.8 million, but gross profit increased by $2.1 million, rising from $1.6 million to $3.7 million, a 131% improvement, with gross margin expanding from 7.6% to 21% [10] Market Data and Key Metrics Changes - Approximately 95% of revenue is supported by domestically sourced raw materials, providing a competitive advantage as tariffs loom [7] - Average daily trading volume increased to roughly 63,000 shares in Q1 2025, a 60% lift compared to Q1 2024, indicating growing market interest [14] Company Strategy and Development Direction - The company is focused on strategic repositioning, actively choosing to exit low-margin business in favor of higher value, technically demanding business [16] - The goal for the Specialty Chemicals segment is to grow from $80 million a year to $120 million by 2030, with growth expected to start in the second half of 2025 [34] Management's Comments on Operating Environment and Future Outlook - Management noted that while there has been some improvement in Q1, demand remains soft, and stabilization activities are still ongoing [30] - The company is committed to capital preservation and disciplined execution while evaluating capital deployment options post-divestiture [22] Other Important Information - The company ended the quarter with $14.3 million in cash and no debt before the divestiture of Bristol assets for $45 million, providing significant flexibility [22] - The company repurchased approximately 17,000 shares at an average price of $12.73, reinforcing confidence in intrinsic value and long-term fundamentals [22] Q&A Session Summary Question: Is the ornamental stainless domestic manufacturer a more attractive target now? - Management indicated that while there are additional looks due to tariffs, demand remains incredibly soft and has not materially changed [30] Question: Will guidance be provided for 2025? - Management stated that it is too premature to provide guidance as stabilization activities are still ongoing [32][33] Question: Is the growth plan for chemicals to reach $120 million by 2030? - Management confirmed that growth is expected to start in the second half of the year, leading to a more compelling top line in 2026 [34] Question: Can this growth be achieved with existing capacity and minimal CapEx? - Management affirmed that organic growth can be achieved with current capacity and a reasonable CapEx assumption of $1 to $3 million per year [37] Question: Is the stock still considered undervalued? - Management expressed a personal opinion that the stock is indeed undervalued at current levels [39]

Financial Data and Key Metrics Changes - Core FFO per share for Q4 2024 was $1.41, a 5.2% increase from the prior year, while the full year core FFO per share was $6.81 [28] - The net debt-to-EBITDA ratio improved to 6x by year-end 2024, with total debt decreasing by $424 million compared to year-end 2023 [8][30] - The company disposed of approximately $570 million of nonstrategic assets throughout 2024 [7][29] Business Line Data and Key Metrics Changes - North American same-property NOI increased by 5.7% in Q4 2024, driven by a 5.8% increase in revenues [22] - Manufactured housing same-property NOI increased by 7.1%, while RV same-property NOI grew by 0.4% [23] - For the full year, North American same-property NOI increased by 4.1%, primarily due to a 4.6% increase in revenues [23] Market Data and Key Metrics Changes - Approximately 70% of revenue-producing site gains came from RV transient to annual conversions [16] - In the U.K., strong unit sales continued to drive real property income [16] Company Strategy and Development Direction - The company is focused on simplifying operations, concentrating on core assets, and improving the balance sheet to achieve steady earnings growth [6] - The recent sale of Safe Harbor Marinas for $5.65 billion is expected to enhance margins, earnings predictability, and revenue to free cash flow conversion [9][10] - The management aims to allocate proceeds from the sale towards debt reduction, shareholder distributions, and reinvestment in core businesses [11][44] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the business's favorable dynamics and predictable earnings, with a clear strategic direction for sustained earnings growth [12][17] - The company is encouraged by positive momentum and aims to maximize revenue and drive operational efficiency [20][21] Other Important Information - The company completed total dispositions of approximately $570 million, including $180 million in Q4 2024 [29] - The company is undergoing a CEO search process while continuing to evaluate capital allocation strategies [8][32] Q&A Session Summary Question: Capital allocation and potential acquisitions - Management indicated that proceeds from the Safe Harbor transaction could be used for debt reduction, shareholder distributions, and reinvestment in core businesses [44] Question: Background on the strategic shift and timing - The board recognized the opportunity to monetize a successful investment and sharpen focus on core segments, leading to the decision to proceed with the transaction [54] Question: Potential for special dividends and debt paydown - Management is evaluating all alternatives regarding the use of proceeds and will provide updates closer to the transaction's closing [58][78] Question: U.K. business expenses and drivers - Increased expenses in the U.K. are primarily due to payroll-related costs, including minimum wage increases and payroll taxes [90] Question: Home sales environment and guidance - The company is focusing on reshaping revenue streams to drive more rental income, despite challenging macroeconomic conditions [99]